Halozyme Reports Fourth Quarter And Full Year 2015 Financial Results

Go back to Halozyme Reports Fourth Quarter And Full Year 2015 Financial Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 68.55 --0 (-0%)
Previous Close $68.55    52 Week High $18.39 
Open $68.55    52 Week Low $6.96 
Day High $68.55    P/E N/A 
Day Low $68.55    EPS $-0.58 
Volume 640